These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9149671)

  • 1. Cancer risk in users of calcium channel blockers.
    Olsen JH; Sørensen HT; Friis S; McLaughlin JK; Steffensen FH; Nielsen GL; Andersen M; Fraumeni JF; Olsen J
    Hypertension; 1997 May; 29(5):1091-4. PubMed ID: 9149671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer risk and mortality in users of calcium channel blockers. A cohort study.
    Sørensen HT; Olsen JH; Mellemkjaer L; Marie A; Steffensen FH; McLaughlin JK; Baron JA
    Cancer; 2000 Jul; 89(1):165-70. PubMed ID: 10897013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark.
    Friis S; Sørensen HT; Mellemkjaer L; McLaughlin JK; Nielsen GL; Blot WJ; Olsen JH
    Cancer; 2001 Nov; 92(9):2462-70. PubMed ID: 11745304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.
    Sørensen HT; Mellemkjaer L; Olsen JH
    Br J Clin Pharmacol; 2001 Sep; 52(3):313-8. PubMed ID: 11560564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
    Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse association between prostate cancer and the use of calcium channel blockers.
    Debes JD; Roberts RO; Jacobson DJ; Girman CJ; Lieber MM; Tindall DJ; Jacobsen SJ
    Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):255-9. PubMed ID: 14973089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular telephones and cancer--a nationwide cohort study in Denmark.
    Johansen C; Boice J; McLaughlin J; Olsen J
    J Natl Cancer Inst; 2001 Feb; 93(3):203-7. PubMed ID: 11158188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study.
    Lindberg G; Bingefors K; Ranstam J; Råstam L; Melander A
    BMJ; 1998 Mar; 316(7133):741-5. PubMed ID: 9529409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk among Danish women with cosmetic breast implants.
    Friis S; Hölmich LR; McLaughlin JK; Kjøller K; Fryzek JP; Henriksen TF; Olsen JH
    Int J Cancer; 2006 Feb; 118(4):998-1003. PubMed ID: 16152592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-lowering medication and risk of cancer.
    Olsen JH; Johansen C; Sørensen HT; McLaughlin JK; Mellemkjaer L; Steffensen FH; Fraumeni JF
    J Clin Epidemiol; 1999 Feb; 52(2):167-9. PubMed ID: 10201659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-channel blockers and risk of cancer.
    Jick H; Jick S; Derby LE; Vasilakis C; Myers MW; Meier CR
    Lancet; 1997 Feb; 349(9051):525-8. PubMed ID: 9048789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-channel blockade and incidence of cancer in aged populations.
    Pahor M; Guralnik JM; Ferrucci L; Corti MC; Salive ME; Cerhan JR; Wallace RB; Havlik RJ
    Lancet; 1996 Aug; 348(9026):493-7. PubMed ID: 8757150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study.
    Ruths S; Bakken MS; Ranhoff AH; Hunskaar S; Engesæter LB; Engeland A
    BMC Geriatr; 2015 Dec; 15():153. PubMed ID: 26626043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term use of antihypertensive drugs and risk of cancer.
    Assimes TL; Elstein E; Langleben A; Suissa S
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1039-49. PubMed ID: 18780400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic drug usage and prostate cancer: a population-based cohort study.
    Kao LT; Huang CC; Lin HC; Huang CY
    Asian J Androl; 2018; 20(1):37-42. PubMed ID: 28857052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study.
    Michels KB; Rosner BA; Walker AM; Stampfer MJ; Manson JE; Colditz GA; Hennekens CH; Willett WC
    Cancer; 1998 Nov; 83(9):2003-7. PubMed ID: 9806660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark.
    Sorensen HT; Friis S; Olsen JH; Thulstrup AM; Mellemkjaer L; Linet M; Trichopoulos D; Vilstrup H; Olsen J
    Hepatology; 1998 Oct; 28(4):921-5. PubMed ID: 9755226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease.
    Smalley WE; Ray WA; Daugherty JR; Griffin MR
    Am J Epidemiol; 1998 Aug; 148(4):350-4. PubMed ID: 9717878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk among statin users: a population-based cohort study.
    Friis S; Poulsen AH; Johnsen SP; McLaughlin JK; Fryzek JP; Dalton SO; Sørensen HT; Olsen JH
    Int J Cancer; 2005 Apr; 114(4):643-7. PubMed ID: 15578694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.